Cynthia Seidel-Dugan
Net worth: 1 M $ as of 30/03/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Timothy Trost | M | 66 | 3 years | |
| Ellen Lubman | F | 48 | 4 years | |
| Michael Sherman | M | 58 | 3 years | |
| Alon Lazarus | M | 49 | 5 years | |
| Derek DiRocco | M | 43 | 4 years | |
| Meeta Chatterjee | M | 69 | 3 years | |
| Briggs Morrison | M | 65 | 5 years | |
| Michael Atkins | M | 69 | - | |
| Randi Isaacs | M | 68 | 4 years | |
| Chulani Karunatilake | M | 65 | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Dan Hicklin | M | 61 |
CoStim Pharmaceuticals, Inc.
 CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology CoStim Pharmaceuticals, Inc. operates as a biotech company which develops biologics for oncology indications. It offers therapies which target immune checkpoint inhibitors for novel treatment. The company was founded on February 01, 2013 and is headquartered in Boston, MA.
Potenza Therapeutics, Inc.
 Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | 5 years |
| Elise T. Wang | F | 64 | - | |
| Sakae Asanuma | M | 57 | 3 years | |
| Reid J. Leonard | M | 65 |
Potenza Therapeutics, Inc.
Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | 9 years |
| Walter Blättler | M | 75 |
CoStim Pharmaceuticals, Inc.
CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology CoStim Pharmaceuticals, Inc. operates as a biotech company which develops biologics for oncology indications. It offers therapies which target immune checkpoint inhibitors for novel treatment. The company was founded on February 01, 2013 and is headquartered in Boston, MA. | 2 years |
| William Winston | M | - | - | |
| Anjili Mathur | F | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 17 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Cynthia Seidel-Dugan
- Personal Network
